According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

January is almost over. For most of us, that means the making and breaking of New Year’s resolutions will (thankfully) be done with for another year.

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

My wife, who bore the brunt of my transformation into a grumpy badger, was the first to suggest I get a sleep study. She’d ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability.

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

“Many [skin care] products have ingredients that are in concentrations that are designed to be what we call in dermatology a ...

Sleep optimization, or, in other words, ‘sleepmaxxing,’ is getting trendy on social media among those prioritizing their sleep routine for some time already. From sleep trackers, mouth taping, nostril ...

I'm 78 and I can't stop snoring. I have type 2 diabetes, a pacemaker and also heart failure. Could it be due to my medication ...